Cysteine cathepsins: regulators of antitumour immune response

Bibliography

• BARRETT AJ, RAWLINGS ND, WOESSNER JF: The Handbook of Proteolytic Enzymes. 2nd ed. Barrett AJ, Rawlings ND, Woessner JF (Eds), Elsevier, Amsterdam (2004).
   Google Scholar
• PUENTE XS, SANCHEZ LM, OVERALL CM, LOPEZ-OTIN C: Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. (2003) 4:544-588.
   PubMed Web of Science ®Google Scholar
• TURK V, TURK B, TURK V: Lysosomal cysteine proteases: facts and opurtunities. EMBO J. (2001) 20:4629-4633.
   PubMed Web of Science ®Google Scholar
• ROBKER RL, RUSSELL DL, ESPEY LL, LYDON JP, O’MALLEY BW, RICHARDS JS: Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA (2000) 97:4689-4694.
   PubMed Web of Science ®Google Scholar
• HONEY K, RUDENSKY AY: Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. (2003) 3:472-482.
   PubMed Web of Science ®Google Scholar
• CHAPMAN HA, RIESE RJ, SHI GP: Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. (1997) 59:63-88.
   PubMed Web of Science ®Google Scholar
• TURK B, TURK D, SALVESEN GS: Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr. Pharm. Dis. (2002) 8:1623-1637.
   PubMed Web of Science ®Google Scholar
• BENAVIDES F, STAROST MF, FLORES M, GIMENEZ-CONTI IB, GUENET JL, CONTI CJ: Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation. Am. J. Pathol. (2002) 161:693-703.
   PubMed Web of Science ®Google Scholar
• KOS J, LAH T: Cysteine proteases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncology Rep. (1998) 5:1349-1361.
   PubMed Web of Science ®Google Scholar
• BUHLING F, ROCKEN C, BRASCH F et al.: Pivotal role of cathepsin K in lung fibrosis. Am. J. Pathol. (2004) 164:2203-2216.
   PubMed Web of Science ®Google Scholar
• FELBOR U, KESSLER B, MOTHES W et al.: Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. USA (2002) 99:7883-7888.
   PubMed Web of Science ®Google Scholar
• LIU J, SUKHOVA GK, YANG JT et al.: Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis (2006) 184:302-311.
   PubMed Web of Science ®Google Scholar
• GELB BD, SHI GP, CHAPMAN HA, DESNICK RJ: Pycnodysosdosis, a lysosomal disease caused by cathepsin K deficiency. Science (1996) 273:1236-1238.
   PubMed Web of Science ®Google Scholar
• LANG A, HORLER D, BAICI A: The relative importance of cysteine peptidases in osteoarthritis. J. Rheumatol. (2000) 27:1970-1979.
   PubMed Web of Science ®Google Scholar
• ELEY BM, COX SW: Advances in periodontal diagnosis. Proteolytic and hydrolytic enzymes link with periodontitis. Br. Dent. J. (1998) 184:323-328.
   PubMed Web of Science ®Google Scholar
• HALANGK W, LERCH MM, BRANDT-NEDELEV B et al.: Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. (2000) 106:773-781.
   PubMed Web of Science ®Google Scholar
• KAWADA A, HARA K, KOMINAMI E, HIRUMA M, NOGUCHI H, ISHIBASHI A: Processing of cathepsins L, B and D in psoriatic epidermis. Arch. Dermatol. Res. (1997) 289:87-93.
   PubMed Web of Science ®Google Scholar
• WEX T, BUHLING F, WEX F et al.: Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum. J. Immunol. (2001) 167:2172-2178
   PubMed Web of Science ®Google Scholar
• TURK B, TURK D, TURK V: Lysosomal cysteine proteases: more than scavengers. Biochim. Biophys. Acta (2000) 1477:98-111.
   PubMed Web of Science ®Google Scholar
• RAWLINGS ND, BARRETT AJ: Evolution of proteins of the cystatin superfamily. J. Mol. Evol. (1990) 30:60-71.
   PubMed Web of Science ®Google Scholar
• ABRAHAMSON M: Cystatins. Methods Enzymol. (1994) 244:685-700.
   PubMed Web of Science ®Google Scholar
• KEPPLER D: Towards novel anti-cancer strategies based on cystatin function. Cancer Lett. (2005) 235:159-176.
   Web of Science ®Google Scholar
• VERDOT L, LAMANCH G, VERCRUYSSE V et al.: Cystatins up-regulate nitric oxide release from interferon-gamma-activated mouse peritoneal macrophages. J. Biol. Chem. (1996) 271:28077-81.
   PubMed Web of Science ®Google Scholar
• GIAIMO R, RICCIO M, SANTI S, GALEOTTI C, AMBROSETTI DC, MELLI M: New insights into the molecular basis of progressive myoclonus epilepsy. A multiprotein complex with cystatin B. Hum. Mol. Genet. (2002) 23:2941-2950.
   Google Scholar
• PREMZL A, ZAVASNIK-BERGANT V, TURK V, KOS J: Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp. Cell Res. (2003) 283:206-214.
   PubMed Web of Science ®Google Scholar
• SCHMITT M, JANICKE F, GRAEFF H: Tumour associated proteases. Fibrinolysis (1992) 6:3-26.
   Google Scholar
• JEDESZKO C, SLOANE BF: Cysteine cathepsins in human cancer. Biol. Chem. (2004) 385:1017-1027.
   PubMed Web of Science ®Google Scholar
• KRUEGER S, HAECKEL C, BUEHLING F, ROESSNER A: Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Cancer Res. (1999) 59:6010-6014.
   PubMed Web of Science ®Google Scholar
• GONDI CS, LAKKA SS, DINH DH, OLIVERO WC, GUJRATI M, RAO JS: RNA-i mediated inhibition of cathepsin B and uPAR leads to decreased cell invasion, angiogenesis and tumour growth in gliomas. Oncogene (2004) 23:8486-8496.
   PubMed Web of Science ®Google Scholar
• VAN NOORDEN CJ, JONGES GN, VAN MARLE J et al.: Heterogenous supression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin. Exp. Metast. (1998) 16:159-167.
   PubMed Web of Science ®Google Scholar
• JOYCE JA, BARUCH A, CHEHADE K et al.: Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell (2004) 5:443-453.
   PubMed Web of Science ®Google Scholar
• KOPITZ C, ANTON M, GANSBACHER B, KRUGER A: Reduction of experimental human fibrosarcoma lung metastasis in mice by adenovirus-mediated cystatin C overexpression. Cancer Res. (2005) 65:8608-8612.
   PubMed Web of Science ®Google Scholar
• VASILJEVA O, PAPAZOGLOU A: KRUGER A et al.: Tumor cell-derived and macrophage derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. (2006) 66:5242-5250.
   PubMed Web of Science ®Google Scholar
• PEPPER A, MONTESANO R: Proteolytic activity and capillary morphogenesis. Cell Diff. Dev. (1990) 32:319-328.
   PubMedGoogle Scholar
• FERRERAS M, FELBOR U, LENHARD T, OLSEN BR, DELAISSE J: Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. (2000) 486:247-251.
   PubMed Web of Science ®Google Scholar
• XU J, RODRIGUES D, PETITCLERC E et al.: Proteolytic exposure of cryptic site within collagen type IV is required for angiogenesis and tumour growth in vivo. J. Cell Biol. (2001) 154:1069-1079.
   PubMed Web of Science ®Google Scholar
• STROJNIK T, KOS J, ZIDANIK B, GOLOUH R, LAH T: Cathepsin B immunohistochemical staining in tumour and endothelial cells is a new prognostic factor for survival in patients with brain tumours. Clin. Cancer Res. (1999) 5:559-567.
   PubMed Web of Science ®Google Scholar
• PREMZL A, TURK V, KOS J: Intracellular proteolytic activity of cathepsin B is associated with capillary-like tube formation by endothelial cells in vitro. J. Cell. Biochem. (2006) 97:1230-1240.
   Google Scholar
• SHI GP, SUKHOVA GK, KUZUYA M et al.: Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. (2003) 92:493-500.
   PubMed Web of Science ®Google Scholar
• URBICH C, HEESCHEN C, AICHER A et al.: Cathepsin L is required for endothelial progenitor cell-induced neurovascularisation. Nat. Med. (2005) 11:206-212.
   PubMed Web of Science ®Google Scholar
• KOBLINSKI JE, AHRAM M, SLOANE BF: Unraveling the role of proteases in cancer. Clin. Chim. Acta (2000) 291:113-135.
   PubMed Web of Science ®Google Scholar
• JAATTELA M: Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene (2004) 23:2746-2756.
   PubMed Web of Science ®Google Scholar
• MUELLER MM, FUSENIG NE: Friends or foes – bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer (2004) 4:836-849.
   Google Scholar
• PHAM CT, ARMSTRONG RJ, ZIMONJIC DB, POPESU NC, PAYAN DG, LEY TJ: Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I. J. Biol. Chem. (1997) 272:10695-10703.
   PubMed Web of Science ®Google Scholar
• RAO NV, RAO GV, HOIDAL JR: Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J. Biol. Chem. (1997) 272:10260-10265.
   PubMed Web of Science ®Google Scholar
• WOLTERS PJ, RAYMOND WW, BLOUNT JL, CAUGHEY GH: Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. J. Biol. Chem. (1998) 273:15514-15520.
   PubMed Web of Science ®Google Scholar
• KOS J, SEKIRNIK A, PREMZL A et al.: Carboxypeptidases cathepsin X and B display distinct protein profile in human cells and tissues. Exp. Cell Res. (2005) 306(1):103-113.
   PubMed Web of Science ®Google Scholar
• ZAVASNIK-BERGANT V, SEKIRNIK A, GOLOUH R, TURK V, KOS J: Immunochemical localisation of cathepsin S, cathepsin L and MHC class II-associated p41 isoform of invariant chain in human lymph node tissue. Biol. Chem. (2001) 382(5):799-804.
   PubMed Web of Science ®Google Scholar
• KOS J, SEKIRNIK A, KOPITAR G et al.: Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br. J. Cancer (2001) 85(8):1193-200.
   PubMed Web of Science ®Google Scholar
• SHI GP, BRYANT RA, RIESE R et al.: Role of cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. (2000) 191(7):1177-1185.
   PubMed Web of Science ®Google Scholar
• OBERMAJER N, PREMZL A, ZAVASNIK-BERGANT T, TURK B, KOS J: Carboxypeptidase cathepsin X mediates beta2-integrin-dependent adhesion of differentiated U-937 cells. Exp. Cell Res. (2006) 312:2515-2527.
   PubMed Web of Science ®Google Scholar
• BROWN GR, MCGUIRE MJ, THIELE DL: Dipeptidyl peptidase I is enriched in granules of in vitro- and in vivo- activated cytotoxic T lymphocytes. J. Immunol. (1993) 150:4733-4742.
   PubMed Web of Science ®Google Scholar
• PUNTURIERI A, FILIPPOV S, ALLEN E et al.: Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med. (2000) 192:789-799.
   PubMed Web of Science ®Google Scholar
• DELAMARRE L, PACK M, CHANG H, MELLMAN I, TROMBETTA ES: Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science (2005) 207:1630-1634.
   Google Scholar
• NAKAGAWA TY, ROTH W, WONG P et al.: Cathepsin L: critical role in Ii degradation and CD4+ T cell selection in the thymus. Science (1998) 280:450-453.
   PubMed Web of Science ®Google Scholar
• BALAJI KN, SCHASCHKE N, MACHLEIDT W, CATALFAMO M, HENKART P: Surface cathepsin B protects cytotoxic lymphocytes from self destruction after degranulation. J. Exp. Med. (2002) 196:493-503.
   PubMed Web of Science ®Google Scholar
• KOBLINSKI JE, DOSESCU J, SAMENI M, MOIN K, CLARK K, SLOANE BF: Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J. Biol. Chem. (2002) 277:32220-32227.
   PubMed Web of Science ®Google Scholar
• KLOSE A, WILBRAND-HENNES A, ZIGRINO P et al.: Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int. J. Cancer (2006) 118:2735-2743.
   PubMed Web of Science ®Google Scholar
• SODERSTORM KO, RINNE R, HOPSU-HAVU VK, JARVINEN M, RINNE A: Identification of acid cysteine protease inhibitor (cystatin A) in human thymus. Anat. Rec. (1994) 240:115-119.
   PubMedGoogle Scholar
• EIDE TJ, JARVINEN M, HOPSU-HAVU VK, MALTAU J, RINNE A: Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix. Acta Histochem. (1992) 93:241-248.
   PubMed Web of Science ®Google Scholar
• JARVINEN M, RINNE A, HOPSU-HAVU VK: Human cystatins in normal and diseased tissues-a review. Acta Histochem. (1987) 82:5-18.
   PubMed Web of Science ®Google Scholar
• HOPSU-HAVU VK, JORONEN IA, JARVINEN M, RINNE A, AALTO M: Cysteine protease inhibitors produced by mononuclear phagocytes. Cell Tissue Res. (1984) 236:161-164.
   PubMed Web of Science ®Google Scholar
• SUZUKI T, HASHIMOTO S, TOYODA N et al.: Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood (2000) 96:2584-2591.
   PubMed Web of Science ®Google Scholar
• ZAVASNIK-BERGANT T, REPNIK U, SCHWEIGER A et al.: Differentiation- and maturation- dependent content, localization, and secretion of cystatin C in human dendritic cells. J. Leukoc. Biol. (2005) 78:122-134.
   PubMed Web of Science ®Google Scholar
• LAUTWEIN A, BURSTER T, LENNON-DUMENIL AM et al.: Inflammatory stimuli recruit cathepsin activity to late endosomal compartments in human dendritic cells. Eur. J. Immunol. (2002) 32:3348-3357.
   PubMed Web of Science ®Google Scholar
• FIEBIGER E, MERANER P, WEBER E et al.: Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. (2001) 193:881-892.
   PubMed Web of Science ®Google Scholar
• LANGERHOLC T, ZAVASNIK-BERGANT V, TURK B, TURK V, ABRAHAMSON M, KOS J: Inhibitory properties of cystatin F and its localization in U-937 promonocyte cells. FEBS J. (2005) 272:1535-1545.
   PubMed Web of Science ®Google Scholar
• KOPITAR-JERALA N: Cystatins in the cells of the immune system-a current view. In: Human Stefins and Cystatins. Zerovnik E (Ed.), Nova Science Publishers, Inc., Hauppauge, NY, USA (2006).
   Google Scholar
• NATHASON CM, WASSELIUS J, WALLIN H, ABRAHAMSON M: Regulated expression and intracellular localization of cystatin F in human U-937 cells. Eur. J. Biochem. (2002) 269:5502-5511.
   PubMedGoogle Scholar
• WERLE B, SCHANZENBACHER U, TURNSEK-LAH T et al.: Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis. Oncol. Rep. (2006) 16:647-655.
   PubMed Web of Science ®Google Scholar
• POLLARD JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer (2004) 4:71-78.
   PubMed Web of Science ®Google Scholar
• SPARMANN A, BAR-SAGI D: Ras induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell (2004) 6:447-458.
   PubMed Web of Science ®Google Scholar
• COUSSENS LM, RAYMOND WW, BERGERS G et al.: Inflammatory mast cell up-regulate angiogenesis during squamous epithelial carcinogenesis. Gene Dev. (1999) 13:1382-1397.
   PubMed Web of Science ®Google Scholar
• WELCH DR, SCHISSEL DJ, HOWREY RP, AEED PA: Tumour-elicited polymorphonuclear cells, in contrast to normal circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. USA (1989) 86:5859-5863
   PubMed Web of Science ®Google Scholar
• KEPPLER D, SIERRA F: Role of cystatins in tumor neovascularization. Future Oncol. (2005) 1:661-672
   PubMedGoogle Scholar
• SMYTH MJ, CROWE NY, GODFREY DI: NK cells and NKT cells collaborate in host protection from methylcholantrene-induced fibrosarcoma. Int. Immunol. (2001) 13:459-463.
   PubMed Web of Science ®Google Scholar
• BALKWILL F, CHARLES KA, MANTOVANI A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 7:211-217.
   PubMed Web of Science ®Google Scholar
• FINCH CE, CRIMMINS EM: Inflammatory exposure and historical changes in human life-spans. Science (2004) 305:1736-1739.
   PubMed Web of Science ®Google Scholar
• SCHWEIGER A, STAIB A, WERLE B et al.: Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking. Br. J. Cancer (2000) 82(4):782-788.
   PubMed Web of Science ®Google Scholar
• KUESTER D, VIETH M, PEITZ U et al.: Upregulation of cathepsin W-expressing T cells is specific for autoimmune athrophic gastritis compared to other types of chronic gastritis. World J. Gastroenterol. (2005) 11(38):5951-5957.
   Web of Science ®Google Scholar
• SCHMIELAU J, FINN OJ: Activated granulocytes and granulocyte derived hydrogen peroxide are the underlying mechanism of supression of T-cell function in advanced cancer patients. Cancer Res. (2001) 61:4756-4760.
   PubMed Web of Science ®Google Scholar
• FINKE J, FERRONE S, FREY A, MUFSON A, ONCHOA A: Where have all the T cells gone? Mechanisms of immune evasion by tumours. Immunol. Today (1999) 20:158-160.
   PubMedGoogle Scholar
• ZOU W: Immunosupressive networks in the tumour microenvironment and their therapeutic relevance. Nat. Rev. Cancer (2005) 5:263-274.
   Google Scholar
• BUHLING F, REISENUER A, GERBER A et al.: Cathepsin K- a marker of macrophage differentiation. J. Pathol. (2001) 195:375-382.
   PubMed Web of Science ®Google Scholar
• LECAILLE F, KALLETA J, BROMME D: Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. (2002) 102:4459-4488
   PubMed Web of Science ®Google Scholar
• HILLMAN GG, KALLINTERIS NL, LU X et al.: Turning tumour cells in situ into T helper cell stimulating, MHC class II tumor epitope presenters: immunocuring and immunoconsolidation. Cancer Treat. Rev. (2004) 30(3):281-290.
   PubMed Web of Science ®Google Scholar
• GIUNTOLI RL 2ND, LU J, KOBAYASHI H, KENNEDY R, CELIS E: Direct costimulation of tumour reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin. Cancer Res. (2002) 8:922-931.
   PubMed Web of Science ®Google Scholar
• CHEEVER MA, CHEN W: Therapy with cultured T cells: principles revisited. Immunol. Rev. (1997) 157:177-194.
   PubMed Web of Science ®Google Scholar
• SCHATTNER EJ, MASCARENHAS J, BISHOP J et al.: CD4+ T-cell induction of Fas mediated apoptosis in Burkitt’s lymphoma B cells. Blood (1996) 88:1375-1382.
   PubMed Web of Science ®Google Scholar
• THOMAS WD, HERSEY P: TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J. Immunol. (1998) 161:2195-2200.
   PubMed Web of Science ®Google Scholar
• BERKE G: Unlocking the secrets of CTL and NK cells. Immunol. Today (1995) 16:343.
   PubMedGoogle Scholar
• KOS FJ, ENGELMAN EG Immune regulation: a critical link between NK cells and CTLs. Immunol. Today (1996) 17:174.
   PubMedGoogle Scholar
• SARIN A, WILLIAMS MS, ALEXANDER-MILLER MA, BERZOFSKY JA, ZACHARCHUK CM, HENKART PA: Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity (1997) 6:209-215.
   PubMed Web of Science ®Google Scholar
• BLAKELY A, GORMAN K, OSTERGAARD H et al.: Resistance of cytotoxic T lymphocytes to lysis by a clone of cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA (1987) 84:3375-3379.
   PubMed Web of Science ®Google Scholar
• JENNE DE, TSCHOPP J: Granzymes: a family of serine proteases in granules of cytolytic T lymphocytes. Immunol. Rev. (1988) 103:53-57.
   Google Scholar
• PHAM CT, LEY TJ: Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA (1999) 96:8627-8632.
   PubMed Web of Science ®Google Scholar
• ONDR JK, PHAM CT: Characterization of murine cathepsin W and its role in cell-mediated cytotoxicity. J. Biol. Chem. (2004) 279:27525-27533.
   Google Scholar
• GUNCČAR G, PUNGERCIC G, KLEMENCIC I, TURK V, TURK D: Crystal structure of MHC class II-associated p41, Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. (1999) 18:793-803.
   PubMed Web of Science ®Google Scholar
• BEVEC T, STOKA V, PUNGERCČICČ G, DOLENC I, TURK V: Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J. Exp. Med. (1996) 183:1331-1338.
   PubMed Web of Science ®Google Scholar
• LENNON-DUMENIL AM, ROBERTS RA, VALENTIN K et al.: The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. (2001) 20:4055-4064.
   PubMed Web of Science ®Google Scholar
• FIEBINGER E, MAEHR R, VILLADANGOS J et al.: Invariant chain controls the activity of extracellular cathepsin L. J. Exp. Med. (2002) 196:1263-1269.
   PubMed Web of Science ®Google Scholar
• BEERS C, HONEY K, FINK S, FORBUSH K, RUDENSKY A: Differential regulation of cathepsin S and cathepin L in interferon gamma-treated macrophages. J. Exp. Med. (2003) 197:169-179.
   PubMed Web of Science ®Google Scholar
• HONEY K, NAKAGAWA T, PETERS C, ALEXANDER R: Cathepsin L regulates CD4+ T cell selection independently of its effects on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. (2002) 195:1349-1358.
   PubMed Web of Science ®Google Scholar
• MAEKAWA Y, HIMENO K, ISHIKAWA H et al.: Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis. J. Immunol. (1998) 161:2120-2127.
   PubMed Web of Science ®Google Scholar
• SHI GP, VILLADANGOS JA, DRANOFF G et al.: Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity (1999) 10:197-206.
   PubMed Web of Science ®Google Scholar
• ZHANG T, MAEKAWA Y, HANBA J et al.: Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of invariant chain in ovalbumin-immunized mice. Immunology (2000) 100:13-20.
   PubMed Web of Science ®Google Scholar
• ONISHI K, LI Y, ISHII K et al.: Cathepsin L is crucial for Th1-type immune response during Leishmania major infection. Microbes Infect. (2004) 6:468-474.
   PubMed Web of Science ®Google Scholar
• DANERI-NAVARRO A, TORO-ARREOLA S, SANCHEZ-HERNANDEZ PE, RAMIREZ-DUENAS MG, ARMENDARIZ-BORUNDA J, PEREZ-MONTFORT R: Immunosupressive activity of proteases in cervical carcinoma. Gynecol. Oncol. (2005) 98:111-117.
   PubMed Web of Science ®Google Scholar
• LOMBARDI G, BURZYN D, MUNDINANO J et al.: Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J. Immunol. (2005) 174:7022-7032.
   PubMed Web of Science ®Google Scholar
• BUHLING F, PEITZ U, KRUGER S et al.: Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa. Biol. Chem. (2004) 385:439-445.
   PubMed Web of Science ®Google Scholar
• DESSAINT JP, KATZ SP, WAKSMAN BH: Catheptic carboxypeptidase as a major component of ‘T-cell activating factor’ of macrophages. J. Immunopharmacol. (1979) 1(3):399-414.
   PubMedGoogle Scholar
• KATZ SP, SHIMAMURA T, DESSAINT JP, BRAVERMAN D, WAKSMAN BH: Mechanisms of action of ‘lymphocyte-activating factor’ (LAF). IV. Differential stimulation of T lymphocytes by induced macrophage enzymes (catheptic carboxypeptidase B and serine proteases). Cell. Immunol. (1980) 56(1):68-79.
   Web of Science ®Google Scholar
• PIERRE P, MELLMAN I: Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell (1998) 93:1135-1145.
   PubMed Web of Science ®Google Scholar
• EL-SUKKARI D, WILSON NS, HAKANSSON K et al.: The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. (2003) 171:5003-5011.
   PubMed Web of Science ®Google Scholar
• KATO T, ITO T, IMATANI T, MINAGUCHI K, SAITOH E, OKUDA K: Cystatin SA, a cysteine proteinase inhibitor, induces interferon-gamma expression in CD4-positive T cells. Biol. Chem. (2004) 385:419-422.
   PubMed Web of Science ®Google Scholar
• HUH CG, HAKANSSON K, NATHANSON CM et al.: Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol. Pathol. (1999) 52:332-340.
   PubMedGoogle Scholar
• KOS J, LAH T: Cystatins in cancer. In: Human Stefins and Cystatins. Zerovnik E (Ed.), Nova Science Publishers, Inc., Hauppauge, NY, USA (2006)
   Google Scholar
• KOS J, KRASOVEC M, CIMERMAN N, NIELSEN HJ, CHRISTENSEN IJ, BRUNNER N: Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin. Cancer Res. (2000) 6:505-511.
   Google Scholar
• LAH TT, DURAN ALONSO MB, VAN NOORDEN CJ: Antiprotease therapy in cancer: hot or not? Expert Opin. Biol. Ther. (2006) 6:257-279.
   PubMed Web of Science ®Google Scholar
• CEGNAR M, KRISTL J, KOS J: Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours. Expert Opin. Biol. Ther. (2005) 5:1557-1569.
   PubMed Web of Science ®Google Scholar